Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards
{{output}}
The expanding availability of multi-omics profiling and advances in artificial intelli-gence (AI) and machine learning (ML) are changing precision oncology. Molecular testing strategies such as longitudinal liquid biopsy assessment, germline variant analysis, ... ...
